The round, led by Polychain Capital, included prominent backers Electric Capital, Coinbase Ventures, FBG Capital, CMS Holdings, Lemniscap, Cygni Labs and Walden Bridge Capital.
When it comes to privacy, Anoma uses a “multi-denomination zero-knowledge transfer circuit,” which enables different types of assets to share one anonymity set.
According to Brink, Anoma’s multi-asset shielded pool is a specific kind of zero-knowledge circuit that allows for private transfers of arbitrary assets.
Nick Saban has a new twist on Conjunction Junction, with a focus on two of the choices: And or but.
HSBC Holdings PLC beat quarterly profit forecasts and released $400 million it had set aside to cover bad loans caused by the pandemic, as rapid vaccine rollouts in the United States and Britain raise hopes for an economic recovery.
General Electric Co’s turnaround plans looked dead in the water to many last spring when its lucrative jet engine business became another victim of the coronavirus pandemic as global air travel dried up.
Basecamp’s leadership seems to be following in the footsteps of Coinbase CEO Brian Armstrong, who in 2020 declared his company apolitical .
The low support, not including abstentions, for the non-binding proposal comes after the Office of the Illinois State Treasurer urged other shareholders to vote “No” on the company’s pay practices, namely because J&J sets aside certain litigation costs when calculating executive compensation, including from the U.S.
That would bolster profit at a time when questions abound as to how sustainable the market flurry will be and the slow pace of vaccination in some countries clouds the outlook.Barclays could beat analysts’ profit forecasts with releases, although such a move is more likely in the second quarter when there’s greater clarity on the success of vaccines, according to Citigroup Inc.GreensillWhile Credit Suisse is front and center when it comes to Greensill Capital, the Swiss lender isn’t the only bank exposed to the fallout from the implosion of the supply chain finance firm.
The Series D funding round is structured as a $225 million investment, with another $300 million equity commitment from SoftBank available at Exscientia’s discretion.“Exscientia’s innovative use of AI to discover and design better quality drugs with greater efficiency has the potential to create important medicines faster than ever before,” SoftBank Investment Advisers’ Managing Partner Eric Chen said in the statement.The company says it has more than 20 projects in development, including two currently in clinical trials, and has partnered with firms including Bristol-Myers Squibb, Bayer AG, and Sanofi, as well as several biotech firms, Chief Financial Officer Ben Taylor said in an email.The investment is SoftBank’s latest in the U.K.
AMC Entertainment Holdings Inc.
So while another blow of as much as $4 billion is likely in the second quarter from the elimination of factoring, that will be excluded from its cash-flow numbers.“We will take great pains as we go through the year to explain it in a way that represents our underlying operating reality,” Culp said.Busy QuarterThe results cap a busy quarter in which GE announced the $30 billion air-leasing deal with AerCap.